Stage IV Colorectal Cancer Completed Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01704703Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive TechniquesTreatment